SIGNet’s functions are to:
- Link network Executive Officers
- Facilitate information sharing and mentoring of new Executive Officers
- Provide an opportunity to share insights on activities done well and to identify solutions to problems
- Provide updates from the sector and to receive updates from ACTA.
SIGNet is ACTA’s Special Interest Group for Network Managers. Each Clinical Trial Network may nominate a representative on SIGNet.
SIGNet provides a forum for Executive Officers, Network Managers and CTN representatives (generally referred to as Executive Officers), to share knowledge and expertise, identify issues, exchange information and engage in collaborative problem solving.
SIGNet currently includes representatives from the following CTNs:
ACEM – Australasian College for Emergency Medicine
AEPCC – Australian Early Psychosis Collaboration Consortium
AGITG – Australasian Gastro-Intestinal Trials Group
AKTN – Australasian Kidney Trials Network
ALLG – Australasian Leukaemia & Lymphoma Group
AMaRC – Australasian Myeloma Research Consortium
ANZACT – Australian and New Zealand Alliance for Cardiovascular Trials
ANZCA – Australian and New Zealand College of Anaesthetists
ANZCHOG – Australian and New Zealand Children’s Haematology/Oncology Group
ANZGOG – Australia New Zealand Gynaecological Oncology Group
ANZICS – Australia & New Zealand Intensive Care Society
ANZMUSC – Australia & New Zealand Musculoskeletal Clinical Trials Network
ANZSA – Australia and New Zealand Sarcoma Association
ANZUP – Australian and New Zealand Urogenital and Prostate Cancer Trials Group
ARTnet – Australasian Radiopharmaceutical Trials Network
ASID – Australasian Society for Infectious Diseases Clinical Research Network
BCT – Breast Cancer Trials
BCRC-WA – Breast Cancer Research Centre - Western Australia
COGNO – Cooperative Trials Group for Neuro-Oncology
CTANZ – Clinical Trials Network Australia and New Zealand
CYMH – Child and Youth Mental Health CTN
DACRIN – NSW Drug and Alcohol Clinical Research and Improvement Network
ICON – Institute of Innovation and Research
MASC – Melanoma and Skin Cancer Trials
MS Research Australia - MS Clinical Trials Network
NECST – National Endometriosis Clinical and Scientific Trials Network
NTA – Neuroscience Trials Australia
OMICO – Australian Genomic Cancer Medicine
PaCCSC – Palliative Care Clinical Studies Collaborative
PACT – Pulmonary Fibrosis Australasian Clinical Trials Network
PC4 – Primary Care Collaborative Cancer Clinical Trials Group
PoCoG – Psycho-oncology Co-operative Research Group
RTN-VIC – Regional Trials Network - Victoria
UQCCR – University of Queensland Centre for Clinical Research
Latest Resources
-
-
Statistical Analysis Plan
-
ACTA Board Charter
-
ACTA Constitution
-
ACTA Trial of the Year Award 2020 guidelines and nomination forms
-
ACTA Year in Review: Financial Year 2018/2019
-
ACTA Resources Brochure
-
ACTA activity work plan 2019 – 2020
-
Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014
-
What a trialist should know about implementation to practice
-
Submission to MRFF Consultation
-
Submission to Medical Research Future Fund Priority Consultation
-
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy
-
ACTA Advisory Council minutes July 2017
-
Economic evaluation of investigator-initiated clinical trials conducted by networks
-
Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results
-
Open letter to the Hon Greg Hunt MP following announcement of MRFF funding for ACTA and clinical trials
-
How can clinical trials networks drive better translation of evidence into better quality care?
-
The Global Perspective: Measuring the impact of Australian-led trials & registries internationally
-
ACTA Summit 2016 – Opening address
-
ACTA Submission to the NHMRC Public Consultation on revisions to sections 3 & 5 of the National Statement
-
ACTA Summit 2016 – Dr Neil Soderlund
-
Medical Research Future Fund set to put high quality evidence at the heart of healthcare – historic moment for all Australians
-
ACTA STInG Submission to the NHMRC Structural Review
-
ACTA Submission to the NHMRC Structural Review
-
ACTA Submission on the MRFF Strategy & Priorities
-
ACTA Submission on the National Safety and Quality Health Service Standards Version 2: Consultation Draft
-
ACTA Submission to the Medicare Benefits Schedule Review Taskforce
-
ACTA Submission to the Community Affairs Legislation Committee on the Medical Research Future Fund Bill 2015
-
ACTA submission on safety monitoring & reporting of clincial trials in Australia
-
Report on the Activities and Achievements of Clinical Trials Networks in Australia 2004-2014
-
ACTA Submission to The Independent Hospital Pricing Authority (IHPA) Teaching, Training and Research Costing Study
-
ACTA Submission on draft Principles for accessing and using publicly funded data for health research
-
WA Health joins national alliance for better evidence in healthcare
-
ACTA submission on revised table of standard costs for clinical trials
-
Report on the ACTA 2014 National Summit of Clinical Trials Networks
Latest News
-
AUSTRALIAN CLINICAL TRIALS ALLIANCE WELCOMES $5 MILLION MEDICAL RESEARCH FUTURE FUND GRANT
-
Save the date: ACTA Summit and Clinical Trials 2020 National Tribute and Award Ceremony
-
ACTA moving to virtual meetings in response to COVID-19
-
Save the date for ACTA Clinical Trials 2020: National Tribute and Awards Ceremony
-
ACTA on Christmas break
-
ACTA—a year in review, 2018-2019 financial year
-
PREDICT (Paediatric Research in Emergency Departments International Collaborative) profile
-
Profiling Melanoma and Skin Cancer Trials
-
ACTA celebrates successful International Clinical Trials Conference
-
Workshop: Pragmatic randomised trial designs for evaluating health policy and practice change interventions
-
New ACTA Resources Brochure
-
Gala Dinner at Doltone House
-
International leaders in Clinical Trials meet in Sydney
-
Pre-Conference workshops
-
Gold Walkley recipient, Dr Norman Swan, confirmed as a speaker at ACTA Conference Gala Dinner
-
Conference speaker and Executive Director of CTTI releases recommendations for mobile technology trials
-
ACTA Annual General Meeting and Advisory Council Meeting
-
Health Economics 101 – designing cost-effectiveness studies alongside trials
-
Federal Minister for Health opening ACTA International Clinical Trials Conference
-
All.Can cancer survey highlights patient experience
-
ACTA Member finds prostate cancer pill gives patients 30% better survival rate
-
ACTA website survey
-
Call for new Members for ACTA’s Reference Groups